Trend Results : American Cancer Society


Blog Post Results (1-20 of 1093)

FILTER RESULTS

Dana-Farber/Brigham and Women's physician wins prestigious recognition from ASH

(Dana-Farber Cancer Institute) Benjamin Ebert, M.D., Ph.D., current chair of Medical Oncology, was presented with recognition at annual American Society of Hematology meeting. Ebert is notable for his leadership in describing the genomic landscape of adult myelodysplastic syndromes (MDS).

People aged 75 years and older are underrepresented in blood cancer clinical trials

(American Society of Hematology) In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the US FDA found significant gaps in participation among those aged 75 and older...Show More Summary

Survivorship care plan improves cancer care-related distress levels for HCT recipients

(Be The Match) Survivorship care plan improves patient cancer care-related distress levels for hematopoietic cell transplant recipients. Results from a recent multicenter study presented at the American Society of Hematology (ASH) Annual Meeting.

CAR T-cell therapies drive outcomes in lymphoma, myeloma

(American Society of Hematology) For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented today at the 59th American Society of Hematology (ASH)Show More Summary

Using software, researchers predict tumor markers that could be immune targets

(UNC Lineberger Comprehensive Cancer Center) Researchers report at the 59th Annual American Society for Hematology Annual Meeting in Atlanta on Saturday, Dec. 9, that they were able to validate their approach for predicting markers - called minor histocompatibility antigens - in a group of patients with blood cancers.

National lung cancer roundtable brings together patients, clinicians, others

(American Cancer Society) The National Lung Cancer Roundtable holds its inaugural meeting on Dec. 11-12, 2017 in Bethesda, Md., the first major meeting for a new nationwide coalition of organizations committed to addressing the challenges of moving lung cancer screening into the mainstream.

Targeted therapies show promise improving outcomes across several hematologic malignancies

(American Society of Hematology) Four studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta highlight the multiple ways in which novel targeted cancer therapies are now being deployed to improve outcomes and quality of life for patients with rare, advanced, or difficult-to-treat blood malignancies.

Mayo Clinic Study Finds Emojis Promising Tool for Tracking Cancer Patients' Quality of Life

In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients' physical, emotional and overall quality of life....Show More Summary

NBA legend Kareem Abdul-Jabbar talks Lonzo, today's bigs, fight against cancer

Abdul-Jabbar will be honored for his work with Coaches vs. Cancer and the American Cancer Society

Dr. Mohamad Cherry of Atlantic Hematology Oncology to Lead Meeting Session and Help Present Multiple Studies at Top International Blood Cancer Meeting

Mohamad Cherry, MD, will lead a major session on new discoveries about the most common type of acute adult leukemia and help present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-12 in Atlanta, GA. Show More Summary

Head and neck cancer researchers to convene for Multidisciplinary Care Symposium February 15-17

(American Society for Radiation Oncology) Researchers will present peer-reviewed abstracts on new combination therapies, targeted therapies, immunotherapy, advanced radiation and surgical techniques, new staging systems, treatment guidelines and supportive care. Show More Summary

John Theurer Cancer Center Researchers Share 46 Cutting Edge Studies at 2017 ASH Meeting

Researchers from the Hackensack Merdian Health John Theurer Cancer Center at Hackensack University Medical Center will present results from 46 cancer-related studies during the American Society of Hematology (ASH) 59th Annual Meeting, which will take place December 9 - 12, 2017 in Atlanta. Show More Summary

MD Anderson to present key drug study findings for multiple blood cancers at ASH annual meeting

(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center will present their latest findings involving drug treatments for blood cancers at the American Society of Hematology's (ASH) Annual Meeting & Exposition Dec. 8-12 in Atlanta.

MD Anderson to Present Key Drug Study Findings for Multiple Blood Cancers at ASH Annual Meeting

Researchers at The University of Texas MD Anderson Cancer Center will present their latest findings involving drug treatments for blood cancers at the American Society of Hematology's (ASH) Annual Meeting & Exposition Dec. 8-12 in Atlanta.

D'Angelo receives American Cancer Society Research Scholar grant

(Sanford-Burnham Prebys Medical Discovery Institute) Maximiliano D'Angelo, Ph.D., an assistant professor at Sanford Burnham Prebys Medical Discovery Institute (SBP), has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society.

D'Angelo Receives American Cancer Society Research Scholar Grant

Maximiliano D'Angelo, Ph.D., an assistant professor at Sanford Burnham Prebys Medical Discovery Institute (SBP), has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society.

Study suggests measurable impact of colorectal cancer screening program

(American Cancer Society) A new study suggests that an American Cancer Society (ACS) program has been effective in promoting improvements in colorectal cancer screening rates in federally qualified health centers

Study calculates contribution of risk factors to cancer in the United States

(American Cancer Society) A new American Cancer Society study calculates the contribution of several modifiable risk factors to cancer occurrence, expanding and clarifying the role of known risk factors, from smoking to low consumption of fruits and vegetables.

People willing to trade treatment efficacy for reduced side effects in cancer therapies

(American Society of Hematology) When choosing their preferred treatment, people with chronic lymphocytic leukemia place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap someShow More Summary

Rutgers Cancer Institute of New Jersey, Rutgers Health and University Hospital Unite with the American Cancer Society in the Fight Against Colorectal Cancer

Rutgers Cancer Institute of New Jersey, Rutgers Health, and University Hospital have committed to increasing colorectal cancer screening across New Jersey by joining a national effort with the American Cancer Society in the fight against this disease.

Copyright © 2015 Regator, LLC